We found that for breast cancer of luminal, luminal-HER2-positive, and TNBC subtypes, which accounted for 86.8% of the subtypes, regularly screened women had a statistically significant higher likelihood of being detected by screening than the irregularly screened women. Here, ERBB2 is linked to breast carcinoma.